Nakamura S - Search Results

1

Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?

Rimini M, Persano M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Piscaglia F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Montes M, Vivaldi C, Soldà C, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Rimassa L, Scartozzi M, Cascinu S, Casadei-Gardini A. Rimini M, et al. Among authors: nakamura s. Target Oncol. 2023 Mar;18(2):221-233. doi: 10.1007/s11523-023-00953-x. Epub 2023 Mar 15. Target Oncol. 2023. PMID: 36920648

2

Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography.

Kaneyoshi T, Nakatsukasa H, Higashi T, Fujiwara K, Naito I, Nouso K, Kariyama K, Kobayashi Y, Uemura M, Nakamura SI, Iwasaki Y, Tsuji T. Kaneyoshi T, et al. Among authors: nakamura si. Clin Cancer Res. 2001 Dec;7(12):4027-32. Clin Cancer Res. 2001. PMID: 11751497

3

Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.

Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, Tsuji T. Yoshida Y, et al. Among authors: nakamura si. Acta Med Okayama. 2001 Dec;55(6):349-55. doi: 10.18926/AMO/32003. Acta Med Okayama. 2001. PMID: 11779097 Free article.

4

Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.

Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T, Shiratori Y. Uemura M, et al. Among authors: nakamura s. Cancer. 2003 May 15;97(10):2474-9. doi: 10.1002/cncr.11374. Cancer. 2003. PMID: 12733146 Free article.

5

Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma.

Matsumoto E, Nakatsukasa H, Nouso K, Kobayashi Y, Nakamura S, Suzuki M, Takuma Y, Tanaka H, Fujikawa T, Shiratori Y. Matsumoto E, et al. Among authors: nakamura s. Liver Int. 2004 Aug;24(4):379-83. doi: 10.1111/j.1478-3231.2004.0923.x. Liver Int. 2004. PMID: 15287862

6

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma.

Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa T, Yumoto Y, Naito I, Shiratori Y. Fujiwara K, et al. Among authors: nakamura s. J Gastroenterol Hepatol. 2004 Oct;19(10):1121-7. doi: 10.1111/j.1440-1746.2004.03467.x. J Gastroenterol Hepatol. 2004. PMID: 15377288

7

Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.

Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E. Sato S, et al. Among authors: nakamura s. Int J Oncol. 2005 Jan;26(1):57-63. Int J Oncol. 2005. PMID: 15586225

8

Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.

Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y. Uematsu S, et al. Among authors: nakamura s. J Gastroenterol Hepatol. 2005 Apr;20(4):583-8. doi: 10.1111/j.1440-1746.2005.03726.x. J Gastroenterol Hepatol. 2005. PMID: 15836707

9

Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival.

Tanaka H, Nouso K, Kobashi H, Kobayashi Y, Nakamura S, Miyake Y, Ohnishi H, Miyoshi K, Iwado S, Iwasaki Y, Sakaguchi K, Shiratori Y. Tanaka H, et al. Among authors: nakamura s. Liver Int. 2006 Jun;26(5):543-51. doi: 10.1111/j.1478-3231.2006.01270.x. Liver Int. 2006. PMID: 16761998

10

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.

Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y. Nakamura S, et al. Am J Gastroenterol. 2006 Sep;101(9):2038-43. doi: 10.1111/j.1572-0241.2006.00681.x. Epub 2006 Jul 18. Am J Gastroenterol. 2006. PMID: 16848811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,138 results

Search Page

Filters